Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Biochemistry|June 24, 2014
Reproducibility and efficiency of serum-derived exosome extraction methodsJosselin Caradec, Geetanjali Kharmate, Elham Hosseini-Beheshti, et al.
Plos One|June 14, 2016
Correction: Epidermal Growth Factor Receptor in Prostate Cancer Derived ExosomesGeetanjali Kharmate, Elham Hosseini-Beheshti, Josselin Caradec, et al.
Plos One|May 7, 2016
Epidermal Growth Factor Receptor in Prostate Cancer Derived ExosomesGeetanjali Kharmate, Elham Hosseini-Beheshti, Josselin Caradec, et al.
Cancers|July 2, 2021
Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase InhibitorsJin Ma, Jiang Ren, Midory Thorikay, et al.
International Journal of Cancer|December 2, 2011
Androgens regulate Hedgehog signalling and proliferation in androgen-dependent prostate cellsNanor Sirab, Stéphane Terry, Frank Giton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate CancerMannan Nouri, Shabnam Massah, Josselin Caradec, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 12, 2026
Tools and Advanced Imaging Technologies for Assessing Intestinal Epithelial Barrier Integrity: A Systematic ReviewSophie Vieujean, Raja Atreya, Andrea Buda, et al.
JBMR Plus|November 27, 2019
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial CellsGonzalo Sánchez-Duffhues, Eleanor Williams, Pascal Benderitter, et al.
Oncotarget|February 2, 2017
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistanceMannan Nouri, Josselin Caradec, Amy Anne Lubik, et al.
Pageof 1